Plain-English translation of NCT06857942 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether —a medication that helps with weight management—can work effectively when added to ixekizumab, a psoriasis treatment you've already been using. Researchers want to see if this combination approach helps people with moderate-to-severe plaque psoriasis who are overweight or have obesity. The study will follow you for up to 12 months to measure how well the treatment works.
Many people with psoriasis also struggle with weight management, which can make other health conditions worse. This trial explores whether combining a weight-loss medication with existing psoriasis treatment might help address both conditions at the same time.
You likely qualify if…
You likely don't qualify if…
You'll continue taking your psoriasis medication (ixekizumab) while adding , which you'll inject yourself under the skin. You'll attend study visits over 12 months where your doctor will monitor how well both your psoriasis and weight are being controlled, and check for any side effects. The study is conducted in real-world clinical practice settings, so visits fit into your normal healthcare routine.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States